Electroencephalography (EEG) Biomarkers of Response in Depression
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
There are two specific aims of this project:
1. To identify physiologic indicators of venlafaxine treatment response using quantitative
EEG (QEEG) cordance, and to determine if cordance changes are specifically associated
with response to venlafaxine
2. To identify predictors of placebo response in major depression using QEEG
cordance/bispectral index (BIS) and neuropsychological testing
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Los Angeles
Collaborators:
Medtronic - MITG Wyeth is now a wholly owned subsidiary of Pfizer